LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, will announce consolidated financial results for the twelve months ended December 31, 2009 and the fourth quarter of 2009 on Wednesday, March 31 after close of market.
